Testing effectiveness (Phase 2)Study completedNCT02589678What this trial is testingZambia SiVET MMR Tdap-IPVWho this might be right forHigh Risk for HIV Emory University 160
Large-scale testing (Phase 3)Study completedNCT00871117What this trial is testingImmunogenicity and Safety of Kinrix + (Measles Mumps Rubella) MMR Vaccine With and Without Varicella Vaccine in Healthy Children 4-6 YearsWho this might be right forTetanusAcellular PertussisDiphtheria GlaxoSmithKline 478
Early research (Phase 1)WithdrawnNCT04799431What this trial is testingNeoantigen-Targeted Vaccine Combined With Anti-PD-1 Antibody for Patients With Stage IV MMR-p Colon and Pancreatic Ductal CancerWho this might be right forPancreatic Cancer MetastaticColorectal Cancer Metastatic Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Large-scale testing (Phase 3)Study completedNCT01702428What this trial is testingConsistency Study of GlaxoSmithKline (GSK) Biologicals' MMR Vaccine (209762) (Priorix) Comparing Immunogenicity and Safety to Merck & Co., Inc.'s MMR Vaccine (M-M-R II), in Children 12 to 15 Months of AgeWho this might be right forRubellaMeaslesMumps GlaxoSmithKline 5,016
Not applicableLooking for participantsNCT05923970What this trial is testingIs a Third Dose of MMRV Vaccine Beneficial for the Adult Population in Alberta?Who this might be right forVaccination FailureVaccine Response Impaired University of Alberta 200
Large-scale testing (Phase 3)Study completedNCT01307436What this trial is testingLong Term Follow-up of a Study to Assess the Safety and Immunogenicity of a Hepatitis A Vaccine Administered With and in the Absence of DTPaHibIPV, OPV and MMR VaccinesWho this might be right forHepatitis A Crucell Holland BV 327
Post-approval studies (Phase 4)Study completedNCT00731965What this trial is testingSafety and Efficacy of Measles, Mumps, Rubella Vaccination in Juvenile Idiopathic ArthritisWho this might be right forArthritis, Juvenile Rheumatoid N.M. Wulffraat 140
Post-approval studies (Phase 4)Study completedNCT00313950What this trial is testingImmunogenicity and Safety of Hepatitis A Vaccine Given at the Same Time of Measles, Mumps, Rubella Combined VaccineWho this might be right forMeaslesMumpsRubella+1 more Sanofi Pasteur, a Sanofi Company 470
Large-scale testing (Phase 3)Study completedNCT06399003What this trial is testingComparison Study of SIBP's MMR Vaccine Versus GSK MMR Vaccine in Children Aged 9-11 MonthsWho this might be right forMeasles-Mumps-Rubella Shanghai Institute Of Biological Products 1,200
Post-approval studies (Phase 4)Study completedNCT03368495What this trial is testingImmunogenicity of Co-administered Yellow Fever and Measles, Mumps, and Rubella (MMR) VaccinesWho this might be right forVaccine Response Impaired Alba Maria Ropero 851
Post-approval studies (Phase 4)UnknownNCT04638985What this trial is testingEvaluation of Immunogenicity and Safety of Combined Immunization of sIPV, DTaP and MMRWho this might be right forVaccine China National Biotec Group Company Limited 600
Post-approval studies (Phase 4)Study completedNCT02880865What this trial is testingImmunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella (MMR) VaccineWho this might be right forEncephalitis, JapaneseMeaslesMumps+1 more PATH 628
Not applicableLooking for participantsNCT06043232What this trial is testingMMR/MSI Phenotypes in Prediction of Tumor Vaccine Benefit for GliomasWho this might be right forGlioma Huashan Hospital 360
Large-scale testing (Phase 3)Ended earlyNCT00839917What this trial is testingProQuad™ in Healthy Children in Korea (V221-023)Who this might be right forMeaslesMumpsRubella+1 more Merck Sharp & Dohme LLC 30
Not applicableStudy completedNCT00962819What this trial is testingMeasles, Mumps, and Rubella (MMR) Immunity in College StudentsWho this might be right forMeaslesMumpsRubella Sri Edupuganti, MD MPH 74
Early research (Phase 1)Active Not RecruitingNCT04117087What this trial is testingPooled Mutant KRAS-Targeted Long Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Resected Mismatch Repair Protein (MMR-p) Colorectal and Pancreatic CancerWho this might be right forColorectal CancerPancreatic Cancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 27
Early research (Phase 1)Looking for participantsNCT06411691What this trial is testingKRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal CancerWho this might be right forColorectal CancerPancreatic Cancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 54
Not applicableStudy completedNCT04646239What this trial is testingBiomarkers of Trained Immunity Following MMR VaccinationWho this might be right forCovid19 Washington University School of Medicine 96
Not applicableWithdrawnNCT01738841What this trial is testingSafety Study of Measles-Mumps-Rubella-Varicella (MMRV) Vaccine, Priorix-Tetra™ in Children Living in the PhilippinesWho this might be right forMumpsRubellaMeasles+1 more GlaxoSmithKline
Large-scale testing (Phase 3)Looking for participantsNCT06855160What this trial is testingA Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of AgeWho this might be right forChickenpox GlaxoSmithKline 900